Pharmacologic Approaches to Preventing Primary Sclerosing Cholangitis Recurrence After Liver Transplantation

NCT06905054 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Primary Sclerosing Cholangitis
Liver Transplant, Complications
PSC
Biliary Strictures

Interventions

DRUG: Fenofibrate (drug)
DIAGNOSTIC_TEST: Blood draw for the laboratory assessment
DIAGNOSTIC_TEST: MRI using a hepatobiliary phase contrast agent (Gd-EOB-DPTA)

Sponsor

Mayo Clinic